Home » Topics » Regulatory

Regulatory
RSS

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Taxol combination therapy approved in France for NSCLC indication

Oct. 16, 1998

Orphan Medical's Busulfex Injection granted priority review

Oct. 8, 1998

HER2 diagnostic test approved in U.S.; will help identify candidates for Herceptin therapy

Oct. 8, 1998

FDA committee recommends approval of Epivir-HBV

Oct. 7, 1998

FDA approves Serevent Diskus for maintenance treatment of pediatric asthma

Oct. 7, 1998

Italian marketing approval obtained for metoclopramide nasal spray

Oct. 5, 1998

FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder

Oct. 5, 1998

First MMP inhibitor cleared for marketing as adjunct in periodontitis

Oct. 2, 1998

A novel use described for the proton pump inhibitor pantoprazole

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...